Ellen Bradley

1.2k total citations · 1 hit paper
25 papers, 483 citations indexed

About

Ellen Bradley is a scholar working on Clinical Psychology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ellen Bradley has authored 25 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Clinical Psychology, 11 papers in Organic Chemistry and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ellen Bradley's work include Psychedelics and Drug Studies (13 papers), Chemical synthesis and alkaloids (11 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Ellen Bradley is often cited by papers focused on Psychedelics and Drug Studies (13 papers), Chemical synthesis and alkaloids (11 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Ellen Bradley collaborates with scholars based in United States, Canada and United Kingdom. Ellen Bradley's co-authors include Cynthia Portal‐Celhay, Martin J. Blaser, Joshua D. Woolley, Joshua Woolley, Jacob S. Aday, Raymond C. Rosen, Steven D. Pratscher, Boris D. Heifets, Aoife O’Donovan and Amanda Khan and has published in prestigious journals such as American Journal of Psychiatry, Neuroscience & Biobehavioral Reviews and Psychological Medicine.

In The Last Decade

Ellen Bradley

20 papers receiving 476 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials

2022 133 citations Jacob S. Aday, Boris D. Heifets et al. Psychopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ellen Bradley United States	10	249	158	96	93	89	25	483
Candace R. Lewis United States	13	141 0.6×	47 0.3×	100 1.0×	8 0.1×	73 0.8×	26	428
Melissa Ferguson United States	12	48 0.2×	13 0.1×	42 0.4×	135 1.5×	45 0.5×	14	730
Ana Cecília de Menezes Galvão Brazil	9	278 1.1×	102 0.6×	164 1.7×	3 0.0×	42 0.5×	16	435
Christopher S. Stauffer United States	11	428 1.7×	284 1.8×	174 1.8×		148 1.7×	29	615
Brett C. Ginsburg United States	16	79 0.3×	10 0.1×	485 5.1×	12 0.1×	31 0.3×	62	797
Cathleen P. Buchanan United States	9	68 0.3×	52 0.3×	113 1.2×	2 0.0×	37 0.4×	12	923
Cecilia Scorza Uruguay	19	130 0.5×	48 0.3×	301 3.1×		43 0.5×	56	787
Andrew C. Harris United States	21	58 0.2×	23 0.1×	560 5.8×	2 0.0×	110 1.2×	51	1.1k
Yasmin Padovan‐Hernandez United States	5	119 0.5×	58 0.4×	125 1.3×	2 0.0×	22 0.2×	8	223
Joy H. Wymer United States	6	345 1.4×	77 0.5×	92 1.0×		30 0.3×	6	506

Countries citing papers authored by Ellen Bradley

Since Specialization

Citations

This map shows the geographic impact of Ellen Bradley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Bradley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Bradley more than expected).

Fields of papers citing papers by Ellen Bradley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Bradley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Bradley. The network helps show where Ellen Bradley may publish in the future.

Co-authorship network of co-authors of Ellen Bradley

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Bradley. A scholar is included among the top collaborators of Ellen Bradley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Bradley. Ellen Bradley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pakhomov, Serguei, et al.. (2025). Bigger But Not Better: Small Neural Language Models Outperform LLMs in Detection of Thought Disorder. PubMed. 2025. 90–105. 1 indexed citations

Haft, Stephanie L., et al.. (2025). A systematic review of participant diversity in psychedelic-assisted psychotherapy trials. Psychiatry Research. 345. 116359–116359. 1 indexed citations

Bradley, Ellen, et al.. (2025). Modifying Informed Consent to Help Address Functional Unmasking in Psychedelic Clinical Trials. JAMA Psychiatry. 82(3). 311–311. 4 indexed citations

Downey, Amanda E., et al.. (2025). Sudden Loss of Consciousness Following Psilocybin Ingestion. American Journal of Psychiatry. 182(12). 1099–1100.

McDaniels, Bradley, Ellen Bradley, Gregory M. Pontone, et al.. (2025). From Hopelessness to Hope: Addressing Demoralization in Parkinson's Disease. Movement Disorders Clinical Practice. 13(1). 71–79.

Bradley, Ellen, Balázs Szigeti, Jill L. Ostrem, et al.. (2025). Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trial. Neuropsychopharmacology. 50(8). 1200–1209. 2 indexed citations

Singleton, S. Parker, Anne Mette Skovgaard, Joseph Francis, et al.. (2025). The allostatic triage model of psychopathology (ATP Model): How reallocation of brain energetic resources under stress elicits psychiatric symptoms. Neuroscience & Biobehavioral Reviews. 179. 106419–106419. 1 indexed citations

Downey, Amanda E., et al.. (2024). A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?. PubMed. 2(2). 61–73.

Bradley, Ellen, et al.. (2024). Quantifying abnormal emotion processing: A novel computational assessment method and application in schizophrenia. Psychiatry Research. 336. 115893–115893.

10.

Aday, Jacob S., et al.. (2024). Psychedelic-assisted psychotherapy: where is the psychotherapy research?. Psychopharmacology. 241(8). 1517–1526. 15 indexed citations

11.

Bradley, Ellen, Gabrielle Agin-Liebes, Emma Morton, et al.. (2024). Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms. Psychopharmacology. 241(8). 1617–1630. 4 indexed citations

12.

Haft, Stephanie L., et al.. (2024). A Systematic Review of Participant Diversity in Psychedelic-Assisted Psychotherapy Trials. OSF Preprints (OSF Preprints).

13.

Aday, Jacob S., et al.. (2023). Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice. PubMed. 1(1). 27–37. 21 indexed citations

14.

Bhardwaj, Anupam, Bernadka Dubicka, Julia Gledhill, et al.. (2022). STAndardised DIagnostic Assessment for children and young people with emotional difficulties (STADIA): protocol for a multicentre randomised controlled trial. BMJ Open. 12(5). e053043–e053043. 7 indexed citations

15.

Aday, Jacob S., Boris D. Heifets, Steven D. Pratscher, et al.. (2022). Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials. Psychopharmacology. 239(6). 1989–2010. 133 indexed citations breakdown →

16.

Khan, Amanda, Ellen Bradley, Aoife O’Donovan, & Joshua Woolley. (2022). Psilocybin for Trauma-Related Disorders. Current topics in behavioral neurosciences. 56. 319–332. 27 indexed citations

17.

Gard, David E., Ellen Bradley, Andrew Penn, et al.. (2021). Evaluating the risk of psilocybin for the treatment of bipolar depression: A review of the research literature and published case studies. Journal of Affective Disorders Reports. 6. 100240–100240. 24 indexed citations

18.

Bradley, Ellen, et al.. (2020). Preliminary evidence that oxytocin does not improve mentalizing in women with schizophrenia. Hormones and Behavior. 128. 104915–104915. 9 indexed citations

19.

Bradley, Ellen, Andrea N. Niles, Katherine P. Rankin, et al.. (2019). Oxytocin increases eye gaze in schizophrenia. Schizophrenia Research. 212. 177–185. 18 indexed citations

20.

Bradley, Ellen & Joshua D. Woolley. (2017). Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward. Neuroscience & Biobehavioral Reviews. 80. 36–56. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact